+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years - 70Years
All Genders
ID07198659

Evaluating Safety and Early Effectiveness of Autologous Drug-Loaded Neutrophils NeuMed with Monomethyl Auristatin E in Adults Aged 18-70 with Unresectable Pancreatic Cancer

Led by The First Affiliated Hospital of Air Force Medicial University · Updated on 2025-09-30

3

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of Autologous Drug-Loaded Neutrophils NeuMed carrying the drug Monomethyl Auristatin E MMAE to treat patients with Unresectable Pancreatic Cancer. This early phase 1, single-arm study aims to verify the safety and assess the anti-tumor effectiveness of this novel therapy in patients whose cancer cannot be removed by surgery. Participants will have their neutrophil cells collected and cultured in a GMP-compliant laboratory, where the cells are loaded with MMAE. Before reinfusion of these neutrophil biological agents, patients receive stereotactic radiotherapy at doses of 2-6 Gy targeted to pancreatic cancer lesions. The reinfused neutrophil dose ranges from 2.0 to 8.0 x 108 cells. During the 12-month study, participants will be monitored closely for safety and treatment effects. Researchers will assess anti-tumor response and record any adverse effects. Evaluations include clinical assessments and laboratory tests to check liver, kidney, and bone marrow function. The total participation period covers treatment and follow-up to understand the therapys safety and preliminary efficacy.

CONDITIONS

Brief Title

A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer

Research Team

L

Liang Jin, Doctor of Medicine(M.D.)

L

Lin Wang, Doctor of Medicine(M.D.)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here